Stockscreener 앱 받기
4.00
6.67%
0.25
Skye Bioscience Inc 주식(SKYE)의 최신 뉴스
What indicators show strength in Skye Bioscience Inc.July 2025 Analyst Calls & Weekly High Momentum Picks - Newser
Should you hold or exit Skye Bioscience Inc. nowJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Can Skye Bioscience Inc. deliver consistent dividendsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - خودرو بانک
How volatile is Skye Bioscience Inc. stockPortfolio Gains Report & AI Powered Market Entry Strategies - خودرو بانک
Rate Hike: Will Skye Bioscience Inc. outperform the market in YEAREarnings Summary Report & Consistent Profit Trading Strategies - خودرو بانک
Custom watchlist performance reports with Skye Bioscience Inc.2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Can swing trading help recover from Skye Bioscience Inc. lossesJuly 2025 Setups & Verified Technical Trade Signals - Newser
Is Skye Bioscience Inc. stock poised for growth2025 Major Catalysts & Safe Capital Growth Plans - Newser
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data - Benzinga
Is Skye Bioscience Inc. building a consolidation base2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Can Skye Bioscience Inc. hit a new high this month2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Chart based analysis of Skye Bioscience Inc. trends2025 Sector Review & Consistent Profit Trading Strategies - Newser
Is Skye Bioscience Inc. vulnerable to short sellersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - خودرو بانک
Sector ETF performance correlation with Skye Bioscience Inc.July 2025 Reactions & Momentum Based Trading Ideas - Newser
How hedge fund analytics apply to Skye Bioscience Inc. stockJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Skye Bioscience Presents Virtual KOL Event Transcript: Interpreting CBeyond Phase IIa Top Line Results - AInvest
Is Skye Bioscience Inc. stock entering bullish territoryMarket Risk Report & Pattern Based Trade Signal System - Newser
Skye Bioscience: A High-Conviction Play in Obesity Innovation Amid Rising R&D Costs - AInvest
Skye Bioscience Reports Promising Results for Nimacimab in Obesity Studies - AInvest
Skye Bioscience reports promising obesity treatment data in mice - Investing.com
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Treatment Weight Maintenance in DIO Model - GlobeNewswire
Will Skye Bioscience Inc. benefit from macro trendsPortfolio Growth Summary & Long-Term Growth Portfolio Plans - Newser
Volume spikes in Skye Bioscience Inc. stock – what they meanWeekly Profit Analysis & High Yield Stock Recommendations - Newser
What MACD signals say about Skye Bioscience Inc.Weekly Trade Review & Expert Verified Stock Movement Alerts - Newser
Is Skye Bioscience Inc. showing signs of accumulationWeekly Profit Recap & Daily Volume Surge Signals - Newser
Multi asset correlation models including Skye Bioscience Inc.July 2025 PreEarnings & Real-Time Price Movement Reports - Newser
Skye Bioscience Inc. stock chart pattern explainedJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Aug Catalysts: Is Skye Bioscience Inc.’s growth already priced inQuarterly Market Summary & Daily Chart Pattern Signals - خودرو بانک
Sentiment analysis tools applied to Skye Bioscience Inc.July 2025 Short Interest & Safe Capital Growth Stock Tips - Newser
Is Skye Bioscience Inc. stock bottoming out2025 Macro Impact & Risk Adjusted Buy/Sell Alerts - Newser
Analyzing drawdowns of Skye Bioscience Inc. with statistical toolsJuly 2025 Decliners & Low Drawdown Investment Strategies - Newser
Real time alert setup for Skye Bioscience Inc. performanceTrade Volume Report & High Return Stock Watch Alerts - Newser
What’s the beta of Skye Bioscience Inc. stockJuly 2025 Trade Ideas & AI Based Buy/Sell Signal Reports - خودرو بانک
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study - GlobeNewswire
Will Skye Bioscience Inc. benefit from seasonalityJuly 2025 Chart Watch & Weekly Chart Analysis and Guides - خودرو بانک
Using AI based signals to follow Skye Bioscience Inc.July 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
What does recent volatility data suggest for Skye Bioscience Inc.July 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
Can Skye Bioscience Inc. maintain its current growth rateJuly 2025 Review & Risk Managed Trade Strategies - خودرو بانک
Is Skye Bioscience Inc.’s growth already priced in2025 Price Momentum & Detailed Earnings Play Strategies - خودرو بانک
What’s the profit margin of Skye Bioscience Inc.Market Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-02 07:19:02 - Newser
Novel Obesity Drug Combined with Wegovy: Skye Completes Phase 2a Trial with 52-Week Extension Study - Stock Titan
How do insiders feel about Skye Bioscience Inc.July 2025 Reactions & Smart Allocation Stock Tips - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):